Clinical Trial Update: A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the safety and efficacy of Prograf plus MR4 in kidney transplantation patients; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• MR4
• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Kidney Transplantation | Phase 3 | Status: COMPLETED